FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\Ppt1S77F
Open Close
General Information
Symbol
Dmel\Ppt1S77F
Species
D. melanogaster
Name
FlyBase ID
FBal0193175
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Nature of the Allele
Progenitor genotype
Cytology
Description

Amino acid replacement: S77F.

Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

C8689750T

Amino acid change:

S77F | Ppt1-PA; S77F | Ppt1-PB

Reported amino acid change:

S77F

Comment:

Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 1 )
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 1 )
 

In humans, Batten disease is characterised by the accumulate abnormal storage material in irregular granular deposits (GRODs) and autofluorescent inclusions in the brain, and the progressive death of neurons in the CNS. The Ppt1S77F, and Ppt1S77F/Ppt1A179T flies show abnormal storage material in highly laminar spherical deposits and increased autofluorescent inclusions. No neurodegeneration detected.

Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Ppt1S77F mutants show no paralysis at elevated temperatures.

Synaptic development appears normal in Ppt1S77F mutants.

Ppt1S77F mutant larvae have locomotion defects. The mutants exhibit significantly shorter average locomotor path lengths compared with those of wild-type larvae.

The brains of Ppt1S77F mutant flies exhibit increased levels of autofluorescent compared to controls. No difference in the levels of autofluorescent deposits is seen in stage 8-17 embryos.

Ppt1S77F mutant embryos display an abnormal complement of eve-positive neural precursors and neurons at stage 11/12. Many hemisegments exhibit a variety of phenotypes including the loss of GMC4.2a, extra RP2/sib neurons, disorganised eve+ clusters, and extra aCC/pCC cells. Later in development at stages 14-15 loss of eve+ RP2s is observed in a small, but significant, percentage of hemisegments.

Ppt1S77F mutant stage 17 embryos show mild to severe CNS axon guidance defects; defects range from mild phenotypes such as irregularly spaced axon tracts in commissures and wavy, thinning longitudinal connectives, to more severe phenotypes such as fused commissures and disorganized CNS tracts. At stage 17 disruption is seen to the Fas2-positive longitudinal connectives. Phenotypes vary in severity ranging from loose and defasiculated connectives to ectopic midline crossing.

Chordotonal neurons (lch5) in the developing PNS are abnormal in many Ppt1S77F mutant stage 17 embryos. Defects include a decreased number of sensory neurons, fused and abnormally shaped neurons, organisational and positional defects and thin axon bundles. No detectable difference is seen in the axon projections in the l, v and v' neuron clusters.

Ppt1A179T/Ppt1S77F mutant embryos display an abnormal complement of eve-positive neural precursors and neurons at stage 11/12. Many hemisegments exhibit a variety of phenotypes including the loss of GMC4.2a, extra RP2/sib neurons, disorganised eve+ clusters, and extra aCC/pCC cells. Later in development at stages 14-16 loss of eve+ RP2s is observed in a small, but significant, percentage of hemisegments.

At stages 14-15, Ppt1S77F/Df(1)446-20 mutant embryos exhibit loss of eve+ RP2s is observed in a small, but significant, percentage of hemisegments.

Ppt1S77F hemizygous males (Ppt1S77F/Y) exhibit light-dependent ommatidial degeneration (ommatidium disruption and rhabdomere loss).

Ppt1S77F/Df(1)446-20 and Ppt1A179T/Ppt1S77F flies accumulate abnormal storage material as laminar deposits in their brains.

Ppt1S77F/Df(1)446-20 and Ppt1A179T/Ppt1S77F flies have more abundant autofluorescent inclusions in the brain than control flies.

The median lifespan of Ppt1S77F/Df(1)446-20 and Ppt1A179T/Ppt1S77F flies is reduced 42 and 20% respectively compared to controls.

The median lifespan of Ppt1S77F hemizygotes is reduced 29% compared to controls.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Enhancer of
Statement
Reference

Ppt1S77F is an enhancer of paralytic | heat sensitive phenotype of shi2

Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference

shi2-Ppt1S77F double mutants paralyze significantly faster when shifted to 27[o]C than do shi2 single mutants.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (1)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (2)
Reported As
Name Synonyms
Secondary FlyBase IDs
    References (6)